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Abstract  
Background: There are significant policy imperatives to involve consumers at the outset of and 
throughout research. How best to achieve this in an authentic and meaningful way is elusive, 
particularly within the palliative care population. 
Aim: To determine how best to engage people with palliative care needs and their families in co-
designing a qualitative study to better understand how to improve care of the dying in the acute 
care setting. 
Methods: A case study design informed this work, informed by pre-determined research 
questions that focused on consumers advising on participant experience within the research, 
rather than research methodology per se. 
Findings: Eleven consumers contributed across five panel meetings. Analysis of documented 
feedback led to four key areas of protocol change: Getting the language in the recruitment 
materials and information and consent forms right; Developing a feasible and acceptable 
recruitment strategy; Opportunities to more clearly articulate the explicit value of this research 
for patients and families; Support strategies for participants. 
Discussion: Authentic consumer engagement requires time and effort; however, the outcomes 




authenticity included: collaboration; preferencing the consumer voice; adequate preparation to 
support consumer engagement; and openness to all feedback provided. 
Conclusion:  Co-designing research with consumers enabled the outcome to be feasible for 
implementation, without any modifications required. Ensuring relevance and consumer-
centredness for the expanding palliative care evidence base is essential and can only be 
achieved through meaningful partnerships with consumer representatives. 
Keywords: Community participation; Palliative care; Case report; Consumers; Patient 
engagement; Quality and Safety. 
Summary of Relevance  
 
o Problem or Issue 
 Policy imperatives call for consumer engagement in the design and implementation of 
research; 
 Achieving meaningful and authentic engagement across palliative care populations is 
unclear. 
o What is Already Known 
 People with palliative care needs, and their families / carers are keen to contribute to 
research; 
 The need for early engagement with consumers, clarity of role at the outset, the valuing 
of consumer contributions and supporting flexible methods for participation is outlined. 
o What this Paper Adds 
 This short report outlines one approach to meaningful consumer engagement in co-
designing a research protocol that sought to understand the experiences of patients with 





There is a growing international policy imperative for involving consumers at the outset of new 
research and implementation projects in order to improve their quality, relevance and impact 
(Canadian Institutes of Health Research, 2011; Cancer Australia and Cancer Voices Australia, 
2011; National Health and Medical Research Council, 2016; NHS Health Research Authority, 
Health and Care Research Wales, & NHS Research Scotland, 2017; Scholz, Bevan, 
Georgousopoulou, Collier, & Mitchell, 2019; The National Institute for Health and Care 
Excellence, 2014). The United Kingdom has led significant work in this area, with additional 
policy and study work evident from Canada, the United States and more recently, Australia 
(Brett et al., 2014). However, achieving authentic consumer (‘patient, carer and/or family’) 
engagement continues to be challenging in many contexts (Ball, Amelia Harshfield, Asha 
Carpenter, Adam Bertscher, & Sonja Marjanovic, 2019; Brett et al., 2014; Daveson et al., 2015; 
Hubbard, Kidd, Donaghy, McDonald, & Kearney, 2007; Oliver, Kothari, & Mays, 2019). A recent 
review found that integrating consumers’ perspectives into projects designed to reform the 
Australian health system and/or care delivery has evolved significantly over the past 20 years in 
relation to their work in developing, implementing and evaluating such work (Consumer Health 
Forum of Australia, 2015 ). However, the need to develop evidence to inform methods for 
effective consumer representation is noted as a priority (Consumer Health Forum of Australia, 
2015 ). National Health and Medical Research Council policy recommends that health and 
medical researchers consider and plan for how they involve consumer representatives in the 
development, conduct and communication of their studies (National Health and Medical 
Research Council, 2016). The uniqueness of every new research project demands targeted 
consumer involvement from the outset (National Health and Medical Research Council, 2016).  
Engaging consumers focused on palliative care in the conceptualisation and development of 




Scholz et al., 2019). Involving such consumers in new research initiatives increases the person 
with palliative care needs’ sense of empowerment, of legacy and of meaning to their days whilst 
living with a terminal illness (Bloomer, Hutchinson, Brooks, & Botti, 2018; Bradburn & Maher, 
2005). Recent consumer focused research has added to our understanding of the perspectives 
and experiences of people with palliative care needs, their family and/or carers, in relation to 
research participation (Aoun, Slatyer, Deas, & Nekolaichuk, 2017; Bloomer et al., 2018; Harrop 
et al., 2016; Pessin et al., 2008; Scholz et al., 2019; Terry, Olson, Ravenscroft, Wilss, & 
Boulton‐Lewis, 2006; White & Hardy, 2010).  
A 2010 systematic review found positive outcomes from research participation for people with 
palliative care needs and their families particularly in relation to altruism and personal gain 
(White & Hardy, 2010). However, this same review notes the importance of participant 
autonomy and the need for trial design to be as simple as possible (to enable participant 
understanding), data collection processes to be minimal to prevent burden on the participant 
and no noted financial burden (White & Hardy, 2010). One large study of family carers identified 
that participants described positive experiences both from an inward-directed perspective 
(sharing of experience, ability for reflection, validation of role) and an outward-directed 
perspective (connection with others) (Aoun et al., 2017). A more recent integrative review 
published in 2018, examining the perspectives and experiences of dying people in relation to 
research participation outlines four themes: (1) the value of research, (2) desire to help, (3) 
expression of self and (4) participation preferences (Bloomer et al., 2018). Beneficial aspects to 
participation including validation of self-worth, altruism and social interaction are well described 
for both people with palliative care needs and their family carers (Aoun et al., 2017; Harrop et 
al., 2016; Pessin et al., 2008; Scholz et al., 2019; Terry et al., 2006). Participation preferences 
were noted to include the desire to be approached by a clinician familiar to the patient or family, 




burdensome for the person both in relation to time investment and/or invasiveness of proposed 
interventions (Bloomer et al., 2018). 
Despite this guidance, there is little evidence to guide clinical researchers as to how best to 
involve consumers in palliative care clinical research (Daveson et al., 2015; Scholz et al., 2019; 
White & Hardy, 2010). A consultation workshop (incorporating expert presentations, discussion 
and nominal group work to develop recommendations) focused on this particular issue, 
suggests that optimal engagement with consumers focused on palliative care in meaningful 
research participation, depends on the following attributes:  
1) Researchers being clear at the outset about a consumer’s role and valuing the contribution 
and difference consumers make to the research outcomes;  
2) Early engagement to aid productivity, quality and relevance;  
3) Flexibility is essential, incorporating multiple methods for participation (virtual and face to 
face) to account for health fluctuations, alternate priorities and responsibilities; and  
4) Assisting consumers to focus on improved productivity, quality and relevance in line with a 
researcher’s agenda is important (Daveson et al., 2015). 
This short report outlines one approach to engaging consumers focused on palliative care in co-
designing a research protocol that sought to understand their experiences of hospital care 
including [for some] stays where a family member died. This case study informed a broader 
program of sequential mixed methods research (Andrew & Halcomb, 2009) focused on how to 
support system level improvements in care for people with palliative care needs in the hospital 




Aim: To determine how best to engage people with palliative care needs and their families in co-
designing a qualitative study to better understand how to improve care of the dying in the acute 
care setting.  
Methods 
An exploratory case study design informed this work (Baxter & Jack, 2008; Yin, 2003) and 
involved people with palliative care needs, bereaved carers and cancer survivors. Pre-
determined research questions were articulated, clear boundaries in relation to the case 
outlined and varied data sources used to enhance understanding (Baxter & Jack, 2008). Of 
note, the two predetermined research questions provided clarity about the purpose for 
consumer input with their focus maintained on participant experience within the research, rather 
than research methodology per se. The research questions for this case study were:  
1. What do consumers perceive to be the best strategies for identifying, approaching and 
recruiting people with palliative care needs, and their families, and supporting 
participation within research focused on optimal hospital-based palliative care? 
2. Do consumers perceive this program of research to be important, and if so, how can we 
best promote this work to a non-clinical audience? 
Ethical approval was not required in the development of this research protocol. Regular 
presentations to and feedback from consumer panels (n=5) occurred throughout protocol design 
with adaptations in response to consumer feedback (Goodyear-Smith, Jackson, & Greenhalgh, 
2015) made until consensus was achieved. Consumer panels were drawn from two 
organisations, one being from a tertiary academic environment’s consumer advisory group and 
the other from a Translational cancer research network’s consumer panel. Members of both 
organisations’ consumer groups included: people living with cancer, cancer survivors, people 




consumer engagement occurred through sending draft documentation for review prior to panel 
meetings and using organisational templates for standardised information provision. These 
templates allowed unique study information to be presented in a manner that provided 
consumer representatives with some consistency of format and data type.  
Descriptive analysis of data from field notes taken within each panel informed research team 
discussions and case study outcomes. Ensuring openness to feedback, even when a difference 
between lay and clinical perspectives occurred, was prioritised throughout all discussions. That 
is, decisions were led by consumer perspectives in relation to the research questions set out 
(consumer participation strategies and communication options). Steps taken to ensure 
prioritisation of the consumer voice included noting and reviewing every individual’s feedback; 
accepting all feedback given in relation to language used to describe our population – that is 
valuing all concerns voiced; openly reviewing all protocol-related changes needed to address 
noted areas of consumer concern and ensuring consensus prior to document finalisation. 
Difficulties in instituting these approaches included the fact that not all consumer 
representatives were present across all panel discussions and the need to truly embrace 
feedback given, even when it did not align with clinical thinking, was challenging. However, the 
lessons learned from such an approach were profound, with the consumer perspective echoing 
the perspective of screening clinicians and potential participants.  
Results 
Eleven consumers (inclusive of bereaved carers (n=7), people with palliative care needs (n=2) 
and cancer survivors (n=2)) contributed, with six attending more than one panel. Five panel 
meetings were conducted and detailed field notes documented at each one. Each panel 
meeting included a 20 minute discussion about this particular piece of work. Analysis of 




participant’s experience from recruitment through to participation. Specifically, feedback focused 
on the following:  
1. Getting the language in the recruitment materials and information and consent forms 
right; 
Consumers were asked for advice about appropriate terminology to describe the study 
population in written study materials. As the study aimed to recruit patients with palliative care 
needs, with a likely prognosis of 12 months of less, this needed to be clearly and sensitively 
articulated in the protocol, ethics application and the participant information sheet. Consumers 
were adamant that terms such as “advanced, progressive illness; advanced and non-curable 
health conditions; people approaching the end of their lives” would be too confronting for many 
patients with palliative care needs and their family members. After several panel discussions, 
and iterations of the participant information sheet, consumers suggested that using the term 
‘serious chronic illness’, was the preferred terminology as it was most likely to be acceptable to 
potential participants and unlikely to cause unnecessary distress. 
However, this broader term presented challenges for the research team as it did not sufficiently 
describe people admitted to hospital who were likely to have a prognosis of 12 months or less. 
However, keeping with co-design principles the team acknowledged that it was important to 
honour and privilege this consumer feedback and to include the preferred term ‘serious chronic 
illness’ in all paperwork seen by potential participants. The screening strategy was devised to 
enable identification of people with a prognosis of 12 months of less (and their families) by 
senior clinicians in accordance with predetermined prognostic screening tools, including the 
Supportive and Palliative Care Indicators Tool (SPICTTM (The University of Edinburgh)) and Australia-
modified Karnofsky Performance Status (AKPS) (Abernethy, Shelby-James, Fazekas, Woods, & 
Currow, 2005). As a result, the inclusion criteria became clearly defined (Table 1) and used 




guidance to the clinician’s screening patients for this study as well as providing them with a 
conversation script to honestly discuss the study with potential participants without causing 
distress. The wording focuses on the fact that participants are living with a serious chronic 
illness but does not refer to it as an advanced illness, prognosis or whether the illness is curable 
or not. This consumer guided advice enabled the team to navigate the complexity of not 
needing to detail prognostic information within the recruitment paperwork. 
Table 1: Inclusion and exclusion criteria for the study 
Inclusion criteria Exclusion criteria 
Clinical indicators of one or multiple life-limiting 
conditions in accordance with the Supportive and 
Palliative Care Indicators Tool (SPICTTM (The 
University of Edinburgh)) 
 Australia-modified Karnofsky Performance Status 
(AKPS)(Abernethy et al., 2005) score between 30 
and 70  
 1 or more admissions to hospital within the previous 
12 months 
 Patient aware they have a serious chronic illness 
 Patient is comfortable talking about their serious 
chronic illness and related care needs 
 Willingness to give verbal informed consent and 
willingness to participate in and comply with the 
study 
 Family member / carer of someone with advanced 
dementia who has had at least 1 hospital 
admission within the previous 12 months 
 Bereaved family member or carer whose loved one 
had at least 1 admission to hospital in their last 12 
months of life and their bereavement is within 2 
years  
Patients less than 18 years of age 
 Patients and / or family members / 
carers who cannot converse in 
English 
 Patients with cognitive impairment 
that impairs their ability to 
describe prior hospitalisations 
and care experiences 
 
 
2. Developing a feasible and acceptable recruitment strategy; 
Initial recruitment strategies discussed with consumer representatives included the use of 




consumer representatives advised that recruitment should be completed by people who knew a 
patient’s care well and were actively involved in their care provision. The reasons for this were 
twofold: 1) To ensure people approached were comfortable with talking about their illness and 
aware of their diagnosis; 2) Consumers felt it would be most appropriate for the first contact to 
be made by someone whom potential participants knew rather than a stranger. This consumer 
advice was also prioritised and an approach using chronic care coordinators, nurse consultants, 
nurse practitioners or medical physicians, working with people who met the screening criteria, 
was developed. This presented the challenge of possible ‘gatekeeping’ in relation to study 
participation. However, the benefits of limiting potential distress for this vulnerable population 
were felt to outweigh the risk of missing eligible people who would have welcomed participation 
but were not given the opportunity to do so by their care coordinator. We also tried to offset this 
risk by providing support and education for the screening clinicians in relation to the importance 
of providing people with opportunities to participate. 
3. Opportunities to more clearly articulate the explicit value of this research for patients and 
families. 
Consumers provided feedback in relation to the difference they perceived between the way this 
study was discussed during face to face panels and how they felt when reading the initial written 
study protocol, participant information sheets and consent forms and invitation letters. The face 
to face discussions allowed an element of the study to emerge that was not as obvious in the 
written materials, with feedback provided that the passion and energy to drive improvements in 
palliative care provision within the hospital setting, as a result of this study, were not evident 
within the paperwork presented. They suggested ensuring that all written study information be 
very patient and family centred and to remain focused on the reasons for undertaking this 
research. Suggestions also included clearly articulating how the research provides important 




enable optimal care and how to measure this, and why the team is so passionate about 
answering these questions. The consumers cautioned against using too much jargonistic 
language, such as ‘system level improvements’ and to avoid dry, policy language. They 
encouraged the development of a lay research summary, which has been crafted and refined 
based on their subsequent feedback. 
4. Support strategies for participants; 
Initial support strategies articulated within our study protocol included linking the patient and/or 
their family member back to their local general practitioner for support as required. However, the 
consumer advice was to also list the supports that their specialist teams could provide, given the 
patients we would be talking with are likely to have complex illnesses and be known to at least 
one specialist clinical team. Consumers felt such people often had closer ties with their 
specialist treating teams at this time than their general practitioners. This was useful feedback 
and easily integrated into the study protocol and the patient information sheet. 
The Human Research Ethics Committee reviewed the research protocol detailing the proposed 
screening, recruitment, consent and participation strategies in relation to the identified 
vulnerable population, being those with palliative care needs and their families, in October 2018. 
This ethics submission was accepted without changes, despite the vulnerability of the 
population and sensitivity of topics to be explored in interviews, and screening and recruitment 
for this study is now underway. The language changes made at the suggestion of consumers, 
have resonated well with screening clinicians who noted that without such changes, their ability 
to recruit effectively would have been significantly impacted. Furthermore, our initial ideas of 
recruiting via databases and providing paperwork naming advanced illness and palliative care 
needs has been noted by screening clinicians as an approach they would have been unhappy 
to be involved with, as so many of their patients have varied perspectives on their illness, 




with the perspectives of clinicians working closely with patients with palliative care needs, and 
their families. 
Discussion 
This case study outlines how one research team worked with consumer representatives to co-
design a research protocol focused on palliative care. There is substantial literature outlining the 
value of integrating the consumer perspective into research design and implementation 
centering around impacts on quality (Brett et al., 2014; Daveson et al., 2015; Scholz et al., 2019; 
Woolf et al., 2016), appropriateness (Brett et al., 2014; Canadian Institutes of Health Research, 
2011; Cancer Australia and Cancer Voices Australia, 2011; Scholz et al., 2019), relevance 
(Daveson et al., 2015; National Health and Medical Research Council, 2016; Scholz et al., 
2019; Woolf et al., 2016), impact (Canadian Institutes of Health Research, 2011; National 
Health and Medical Research Council, 2016; Scholz et al., 2019; Woolf et al., 2016), improved 
outcomes and experiences for patients and families (Cancer Australia and Cancer Voices 
Australia, 2011; National Health and Medical Research Council, 2016), ethical respect for 
vulnerable populations (Woolf et al., 2016) and developing a research active nation (Daveson et 
al., 2015; National Health and Medical Research Council, 2016). However, barriers to such 
participation have also been noted, including a lack of clarity about the purpose and role of a 
consumer representative (Ball et al., 2019; Nathan, Johnston, & Braithwaite, 2011; National 
Health and Medical Research Council, 2016), inadequate preparation for consumer 
representatives (Ball et al., 2019; Consumer Health Forum of Australia, 2015 ; National Health 
and Medical Research Council, 2016; Woolf et al., 2016), tokenism (Ball et al., 2019; National 
Health and Medical Research Council, 2016), and tension in relation to the balance between lay 
and clinical perspectives (Ball et al., 2019; Beckett, Farr, Kothari, Wye, & le May, 2018; Martin & 
Finn, 2011; National Health and Medical Research Council, 2016; Scholz et al., 2019).Planning 




essential to enable such barriers to be overcome (Ball et al., 2019; Cancer Australia and Cancer 
Voices Australia, 2011; National Health and Medical Research Council, 2016). This case study 
addressed such concerns through: collaborating to co-design a research protocol with clarity 
about the purpose for consumer engagement focusing on participant experience within the 
research, rather than research methodology per se; carefully considering how to value the 
consumer voice; ensuring adequate preparation for meaningful consumer engagement through 
sending draft documentation for review prior to meetings; ensuring openness to feedback even 
when a difference between lay and clinical perspectives was noted and felt challenging. This 
process was time consuming and required work; however, the outcomes of a feasible and 
acceptable screening and recruitment strategy for a vulnerable population (being those with 
palliative care needs) were well worth the invested time and energy. Discussions with screening 
clinicians continue to underscore the importance of the change in our early thinking in relation to 
language and planned approaches to access our defined population; that was fully precipitated 
by consumer co-design. Although some of the feedback provided at the commencement of the 
protocol co-design was difficult to hear and accommodate, the principals of committing to 
meaningful consumer engagement and prioritising their feedback in relation to the pre-designed 
feedback questions enabled successful discussions, consensus building and eventual protocol 
finalisation.   
Significant progress in relation to meaningful engagement with consumer representatives within 
research design, conduct and reporting has occurred over the past decade (Ball et al., 2019; 
Woolf et al., 2016), with some of this progress credited to the work led by the Patient-Centered 
Outcomes Research Institute (PCORI) (Frank, Basch, & Selby, 2014; Selby, Forsythe, & Sox, 
2015). PCORI is a non-governmental organisation, established in 2010 in the United States, 
with a noted mandate to ‘improve the quality and relevance of evidence available to help 




health decisions’ (Patient-Centered Outcomes Research Institute, 2017) and they do so in a 
variety of ways, one being to ensure engagement of patients and family members across all 
stages of the research cycle. However, the need to continue to look at each unique study and 
how co-design can enhance question generation, protocol design, implementation and 
dissemination is vital, with some areas of research perhaps benefitting more than others (Oliver 
et al., 2019). Consumer participation is widely recognised as important within cancer services 
and cancer research (Cancer Australia and Cancer Voices Australia, 2011); however, the 
progression of this within palliative care remains emerging (Bloomer et al., 2018) and therefore 
careful consideration about how to achieve this is important. This case study provides evidence 
of one such approach which worked well for this particular study. Like so many areas of 
healthcare, a personalised approach to meaningful consumer participation is essential to ensure 
this work can reach its potential (Oliver et al., 2019). This can be challenging and requires 
significant effort; however, when successfully achieved, it can vitalise work, enhance its 
relevance and increase its application into practice (Woolf et al., 2016).  
Strengths and limitations 
The strength of this work lies within the clear establishment of aims for consumer participation, 
informed by the predesigned research questions. This enabled clarity about the purpose of the 
consumer role which helped the team to provide the consumers with the necessary content to 
make an informed contribution. This step, in turn helped to focus the consumer panel discussion 
to optimise the consumers input in a timely way. Furthermore, the upfront clarification of 
consumer role enabled the research team to privilege the consumer’s feedback in relation to the 
set research questions and this informed discussions and consequently outcomes. The 
limitation of the approach taken was that the team did not seek consumer feedback about the 
engagement process and actual experience of contributing to co-designing the research 




consensus on the preferred wording and framing of the research protocol was achieved, it 
would have been useful to have sought consumer feedback about the processes used and 
outcomes gained. 
Recommendations for future research 
This short report highlights the importance and value of meaningful consumer engagement at all 
stages of the research process, from the initial idea, through to the development of the concept 
through to implementation into practice. However, this report demonstrates the importance of 
clearly articulating the consumer representative’s role and for this role to be understood by both 
the consumers and the research team. This short report describes one method for establishing 
research questions specifically for the consumer roles focused on appropriateness of the study 
question through to accessibility and experience for potential participants within the proposed 
study. It would be helpful to research such approaches more systematically through establishing 
mechanisms for consumer feedback in relation to approach taken and ability for meaningful 
engagement for all involved.Conclusion 
Significant policy work outlines the importance of engaging with consumers throughout the 
development and implementation of research. Preferencing consumer data and engaging 
meaningfully with consumer representatives has enabled this case study to remain focused on 
that which is of most importance to people with palliative care needs, and their families. Co-
designing a research protocol with consumers focused on palliative care enabled the outcome 
to be feasible for implementation within a clinical setting, without any modifications required. 
Ensuring relevance and consumer-centredness for the expanding palliative care evidence base 
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